Trial drug can significantly block early stages of COVID-19 in engineered human tissues

by ossmanagement_5ljjkf • April 2, 2020

An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts. …read more

Source:: Science

TensorFlow: A cheat sheet

How to use NGINX as a reverse proxy for Apache

Google: We're funding developers to work full-time on Linux security

Nextcloud 21: Improvements in speed and added features make its cloud offering more business-friendly

How to integrate the Nautilus file manager with Git

Windows Subsystem for Linux 2: The GUI features developers have been asking for